gypenoside-LXXV and Diabetes-Mellitus--Type-2

gypenoside-LXXV has been researched along with Diabetes-Mellitus--Type-2* in 1 studies

Other Studies

1 other study(ies) available for gypenoside-LXXV and Diabetes-Mellitus--Type-2

Article	Year
A novel natural PPARγ agonist, Gypenoside LXXV, ameliorates cognitive deficits by enhancing brain glucose uptake via the activation of Akt/GLUT4 signaling in db/db mice. Phytotherapy research : PTR, 2022, Volume: 36, Issue:4 Topics: Animals; Brain; Cognition; Cognitive Dysfunction; Diabetes Mellitus, Type 2; Glucose; Glucose Transporter Type 4; Gynostemma; Insulin; Insulin Resistance; Mice; PPAR gamma; Proto-Oncogene Proteins c-akt; Saponins; Triterpenes	2022

Article

Year

A novel natural PPARγ agonist, Gypenoside LXXV, ameliorates cognitive deficits by enhancing brain glucose uptake via the activation of Akt/GLUT4 signaling in db/db mice.

Phytotherapy research : PTR, 2022, Volume: 36, Issue:4

Topics: Animals; Brain; Cognition; Cognitive Dysfunction; Diabetes Mellitus, Type 2; Glucose; Glucose Transporter Type 4; Gynostemma; Insulin; Insulin Resistance; Mice; PPAR gamma; Proto-Oncogene Proteins c-akt; Saponins; Triterpenes

2022